Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study

被引：0
|
作者：
Kosuke Ebina
Toru Hirano
Yuichi Maeda
Wataru Yamamoto
Motomu Hashimoto
Koichi Murata
Akira Onishi
Sadao Jinno
Ryota Hara
Yonsu Son
Hideki Amuro
Tohru Takeuchi
Ayaka Yoshikawa
Masaki Katayama
Keiichi Yamamoto
Makoto Hirao
Yasutaka Okita
Atsushi Kumanogoh
Ken Nakata
机构：
[1] Osaka University,Department of Musculoskeletal Regenerative Medicine
[2] Graduate School of Medicine,Department of Respiratory Medicine and Clinical Immunology
[3] Osaka University,Department of Health Information Management
[4] Graduate School of Medicine,Department of Advanced Medicine for Rheumatic diseases, Graduate School of Medicine
[5] Kurashiki Sweet Hospital,Department of Rheumatology and Clinical Immunology
[6] Kyoto University,The Center for Rheumatic Diseases
[7] Kobe University Graduate School of Medicine,First Department of Internal Medicine
[8] Nara Medical University,Department of Internal Medicine (IV)
[9] Kansai Medical University,Department of Rheumatology
[10] Osaka Medical College,Information Technology Center
[11] Osaka Red Cross Hospital,Department of Orthopaedic Surgery
[12] Wakayama Medical University Hospital,Department of Health and Sport Sciences
[13] Osaka University,undefined
[14] Graduate School of Medicine,undefined
[15] Osaka University,undefined
[16] Graduate School of Medicine,undefined
来源：
Clinical Rheumatology | 2021年 / 40卷
关键词：
ANSWER cohort; Baricitinib; Drug retention; Rheumatoid arthritis; Sarilumab; Tofacitinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2673 / 2680
页数：7
相关论文
共 50 条
  • [1] Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study
    Ebina, Kosuke
    Hirano, Toru
    Maeda, Yuichi
    Yamamoto, Wataru
    Hashimoto, Motomu
    Murata, Koichi
    Onishi, Akira
    Jinno, Sadao
    Hara, Ryota
    Son, Yonsu
    Amuro, Hideki
    Takeuchi, Tohru
    Yoshikawa, Ayaka
    Katayama, Masaki
    Yamamoto, Keiichi
    Hirao, Makoto
    Okita, Yasutaka
    Kumanogoh, Atsushi
    Nakata, Ken
    [J]. CLINICAL RHEUMATOLOGY, 2021, 40 (07) : 2673 - 2680
  • [2] Drug retention of 7 biologics and tofacitinib in biologics-naive and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
    Ebina, Kosuke
    Hirano, Toru
    Maeda, Yuichi
    Yamamoto, Wataru
    Hashimoto, Motomu
    Murata, Koichi
    Takeuchi, Tohru
    Shiba, Hideyuki
    Son, Yonsu
    Amuro, Hideki
    Onishi, Akira
    Akashi, Kengo
    Hara, Ryota
    Katayama, Masaki
    Yamamoto, Keiichi
    Kumanogoh, Atsushi
    Hirao, Makoto
    [J]. ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [3] Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study
    Ebina, Kosuke
    Etani, Yuki
    Maeda, Yuichi
    Okita, Yasutaka
    Hirao, Makoto
    Yamamoto, Wataru
    Hashimoto, Motomu
    Murata, Koichi
    Hara, Ryota
    Nagai, Koji
    Hiramatsu, Yuri
    Son, Yonsu
    Amuro, Hideki
    Fujii, Takayuki
    Okano, Takaichi
    Ueda, Yo
    Katayama, Masaki
    Okano, Tadashi
    Tachibana, Shotaro
    Hayashi, Shinya
    Kumanogoh, Atsushi
    Okada, Seiji
    Nakata, Ken
    [J]. RMD OPEN, 2023, 9 (03):
  • [4] DRUG RETENTION OF 7 BIOLOGICS AND TOFACITINIB IN BIOLOGICS-NAIVE AND BIOLOGICS-SWITCHED PATIENTS WITH RHEUMATOID ARTHRITIS-THE ANSWER COHORT STUDY
    Ebina, K.
    Hirano, T.
    Maeda, Y.
    Yamamoto, W.
    Hashimoto, M.
    Murata, K.
    Takeuchi, T.
    Shiba, H.
    Son, Y.
    Amuro, H.
    Onishi, A.
    Akashi, K.
    Hara, R.
    Katayama, M.
    Yamamoto, K.
    Kumanogoh, A.
    Hirao, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 18 - 19
  • [5] Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
    Kosuke Ebina
    Toru Hirano
    Yuichi Maeda
    Wataru Yamamoto
    Motomu Hashimoto
    Koichi Murata
    Tohru Takeuchi
    Hideyuki Shiba
    Yonsu Son
    Hideki Amuro
    Akira Onishi
    Kengo Akashi
    Ryota Hara
    Masaki Katayama
    Keiichi Yamamoto
    Atsushi Kumanogoh
    Makoto Hirao
    [J]. Arthritis Research & Therapy, 22
  • [6] Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study
    Ebina, Kosuke
    Hirano, Toru
    Maeda, Yuichi
    Yamamoto, Wataru
    Hashimoto, Motomu
    Murata, Koichi
    Onishi, Akira
    Jinno, Sadao
    Hara, Ryota
    Son, Yonsu
    Amuro, Hideki
    Takeuchi, Tohru
    Yoshikawa, Ayaka
    Katayama, Masaki
    Yamamoto, Keiichi
    Okita, Yasutaka
    Hirao, Makoto
    Etani, Yuki
    Kumanogoh, Atsushi
    Okada, Seiji
    Nakata, Ken
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [7] Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study
    Kosuke Ebina
    Toru Hirano
    Yuichi Maeda
    Wataru Yamamoto
    Motomu Hashimoto
    Koichi Murata
    Akira Onishi
    Sadao Jinno
    Ryota Hara
    Yonsu Son
    Hideki Amuro
    Tohru Takeuchi
    Ayaka Yoshikawa
    Masaki Katayama
    Keiichi Yamamoto
    Yasutaka Okita
    Makoto Hirao
    Yuki Etani
    Atsushi Kumanogoh
    Seiji Okada
    Ken Nakata
    [J]. Scientific Reports, 12
  • [8] DRUG RETENTION AND REASONS FOR DISCONTINUATION OF BIOLOGICS AND JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS - THE ANSWER COHORT STUDY
    Ebina, K.
    Etani, Y.
    Maeda, Y.
    Okita, Y.
    Hirao, M.
    Yamamoto, W.
    Hashimoto, M.
    Murata, K.
    Hara, R.
    Nagai, K.
    Hiramatsu, Y.
    Son, Y.
    Amuro, H.
    Fujii, T.
    Okano, T.
    Ueda, Y.
    Katayama, M.
    Okano, T.
    Kumanogoh, A.
    Okada, S.
    Nakata, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 234 - 235
  • [9] Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis
    Martinez-Molina, Cristina
    Diaz-Torne, Cesar
    Park, Hye S.
    Feliu, Anna
    Vidal, Silvia
    Corominas, Hector
    [J]. MEDICINA-LITHUANIA, 2024, 60 (03):
  • [10] Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study-
    Ebina, Kosuke
    Hashimoto, Motomu
    Yamamoto, Wataru
    Ohnishi, Akira
    Kabata, Daijiro
    Hirano, Toru
    Hara, Ryota
    Katayame, Masaki
    Yoshida, Shuzo
    Nagai, Koji
    Son, Yonsu
    Amuro, Hideki
    Akashi, Kengo
    Fujimura, Takanori
    Hirao, Makoto
    Yamamoto, Keiichi
    Shintani, Ayumi
    Kumanogoh, Atsushi
    Yoshikawa, Hideki
    [J]. PLOS ONE, 2018, 13 (03):
12345